Similar articles for PMID: 12400015

Year	Number of Results
1978	1
1979	1
1980	1
1981	1
1984	1
1987	2
1988	3
1989	3
1990	5
1991	1
1992	3
1993	3
1994	6
1995	8
1996	7
1997	14
1998	14
1999	24
2000	40
2001	36
2002	57
2003	42
2004	14
2005	9
2006	12
2007	12
2008	18
2009	20
2010	23
2011	18
2012	20
2013	18
2014	19
2015	10
2016	16
2017	9
2018	12
2019	13
2020	4
2021	9
2022	7
2023	2
2024	0

1

Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.

Kawai H, Li H, Chun P, Avraham S, Avraham HK. Kawai H, et al. Oncogene. 2002 Oct 31;21(50):7730-9. doi: 10.1038/sj.onc.1205971. Oncogene. 2002. PMID: 12400015

2

Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.

Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M. Buteau-Lozano H, et al. Cancer Res. 2002 Sep 1;62(17):4977-84. Cancer Res. 2002. PMID: 12208749

3

Role of direct interaction in BRCA1 inhibition of estrogen receptor activity.

Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, Wang JA, Erdos M, Goldberg ID, Webb P, Kushner PJ, Pestell RG, Rosen EM. Fan S, et al. Oncogene. 2001 Jan 4;20(1):77-87. doi: 10.1038/sj.onc.1204073. Oncogene. 2001. PMID: 11244506

4

Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor.

Hyder SM, Nawaz Z, Chiappetta C, Stancel GM. Hyder SM, et al. Cancer Res. 2000 Jun 15;60(12):3183-90. Cancer Res. 2000. PMID: 10866309

5

p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.

Liang Y, Wu J, Stancel GM, Hyder SM. Liang Y, et al. J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):173-82. doi: 10.1016/j.jsbmb.2004.12.011. Epub 2005 Jan 28. J Steroid Biochem Mol Biol. 2005. PMID: 15860260

6

Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins.

Stoner M, Wormke M, Saville B, Samudio I, Qin C, Abdelrahim M, Safe S. Stoner M, et al. Oncogene. 2004 Feb 5;23(5):1052-63. doi: 10.1038/sj.onc.1207201. Oncogene. 2004. PMID: 14647449

7

Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.

Xiong S, Grijalva R, Zhang L, Nguyen NT, Pisters PW, Pollock RE, Yu D. Xiong S, et al. Cancer Res. 2001 Feb 15;61(4):1727-32. Cancer Res. 2001. PMID: 11245489

8

Activation of vascular endothelial growth factor (VEGF) by the ER-alpha variant, ERDelta3.

Koduri S, Goldhar AS, Vonderhaar BK. Koduri S, et al. Breast Cancer Res Treat. 2006 Jan;95(1):37-43. doi: 10.1007/s10549-005-9028-4. Breast Cancer Res Treat. 2006. PMID: 16267616

9

1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.

Swami S, Krishnan AV, Feldman D. Swami S, et al. Clin Cancer Res. 2000 Aug;6(8):3371-9. Clin Cancer Res. 2000. PMID: 10955825

10

Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter.

Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW. Stevens A, et al. Cancer Res. 2003 Feb 15;63(4):812-6. Cancer Res. 2003. PMID: 12591731

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

514 results

Results by year